Screener
Alnylam Pharmaceuticals ALNY Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from Alnylam Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: Alnylam Pharmaceuticals’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 8:11 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001178670-26-000062
FAQ
- What is Alnylam Pharmaceuticals's free cash flow margin?
- Alnylam Pharmaceuticals (ALNY) reported free cash flow margin of 16.5% in Q2 2026.
- How has Alnylam Pharmaceuticals's free cash flow margin changed year-over-year?
- Alnylam Pharmaceuticals's free cash flow margin increased by 881.1% year-over-year, from -2.1% to 16.5%.
- What is the long-term trend for Alnylam Pharmaceuticals's free cash flow margin?
- Over 4 years (2020 to 2025), Alnylam Pharmaceuticals's free cash flow margin has grown at a -45.2% compound annual growth rate (CAGR), from -139.1% to 12.5%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.
Ask your AI about Alnylam Pharmaceuticals's free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude